Antibiotic

Barriers to an early antimicrobial conversion from parenteral to non-parenteral routes are an important problem in the current scenario. Barriers such as a lack of appropriate guidelines for conversion therapies, a lack of culture sensitivity tests for selecting sensitive antibiotics, a lack of supervision by healthcare professionals on converted regimens, a lack of awareness among the patient population about the effectiveness of conversion therapy, and a lack of oral variant antibiotics for its intravenous agents on the market must be identified and resolved. The majority of barriers could be resolved by means of educational, interventional, and structural organizational changes. This may reduce the duration of parenteral antibiotic therapy and the consequent length of stay in hospital. This article review focuses on barriers involved in intravenous to oral antimicrobial conversion therapy and their rectifiable methods. Antibiotics are the most powerful weapons for infectious diseases and could be used in the most appropriate manner by resolving the barriers involved in such conversion therapies and improving the quality of life.

This research is prepared is on “To Study the doctor’s perception while prescribing the antibiotic – cefixime in Mumbai, thane. This research paper has been presented based on my observation and experience gathered from field survey in macron lab. An organization has many divisions and departments but focus is given more on the level of brand strategy of the marketing department specially in the pharmaceutical industries due to the high competition. this survey evaluates knowledge, attitudes and perception of doctor about prescribing the antibiotic - cefixime. This study also helped to learn about Several factors influenced prescribing, including patients' expectations, severity and duration of infections. The result of the research is described in details in this report. After knowing the perception and brand image of the antibiotic cefixime a lot of finding came up. The research also consists of recommendations and conclusion according to my point of view which would improve the prescription of doctors towards the antibiotic (gramocef-o) which is manufactured by macron labs.